Macrophages and immunologic inflammation of the kidney.
Monocyte-derived tissue effector cells, macrophages, are present in large numbers in all forms of kidney disease with inflammation. Their roles in inflammation and the molecular effectors of macrophage function have been difficult to decipher. With the advent of modern genetic tools and mouse models of human disease, great insight into monocyte/macrophage biology has been forthcoming. This review places macrophage study in its historical context, defines immunologic diseases of the kidney, broadens its definition to encompass current thinking of the immune response to kidney injury, highlights key advances of the study of monocyte/macrophages in kidney diseases, and identifies new therapeutic pathways and targets that hinge around macrophage function. This article advances the case that targeting macrophage activation and phenotype is leading to new therapies in the treatment of many acute and chronic kidney diseases.
Duffield
Jeremy S
JS
Laboratory of Inflammation Research, Renal Division, Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA. jduffield@rics.bwh.harvard.edu
D000208:Acute Disease; D000818:Animals; D015551:Autoimmunity; D002908:Chronic Disease; D005355:Fibrosis / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007668:Kidney / Q000473:pathology; D008262:Macrophage Activation; D008264:Macrophages / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D009000:Monocytes / Q000187:drug effects; D009393:Nephritis / Q000188:drug therapy / Q000276:immunology*; D051381:Rats